Get the Stockscreener App
103.05
0.12%
-0.12
Boston Scientific Corp stock is traded at $103.05, with a volume of 8.52M.
It is down -0.12% in the last 24 hours and down -0.57% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$103.17
Open:
$103
24h Volume:
8.52M
Relative Volume:
1.18
Market Cap:
$152.69B
Revenue:
$18.49B
Net Income/Loss:
$2.50B
P/E Ratio:
61.34
EPS:
1.68
Net Cash Flow:
$3.49B
1W Performance:
+0.29%
1M Performance:
-0.57%
6M Performance:
-2.18%
1Y Performance:
+31.69%
1-Day Range:
$102.18
$103.36
1-Week Range:
$101.62
$104.65
52-Week Range:
$77.71
$108.53
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
103.05 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
130.27 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
381.61 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.30 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Insider Selling Trends in Nasdaq-Listed Companies: A Cautionary Lens on Alnylam, Boston Scientific, and CSX - AInvest
Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT - ca.finance.yahoo.com
Boston Scientific Tumbles 0.94% as Volume Dives 26.54% to 186th Despite IBD Rating Surge to 71 - AInvest
Former FDA Director, Boston Scientific Leaders Join Keyron’s Board - Medical Product Outsourcing
12 Best Stocks to Invest in For Beginners - Insider Monkey
FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads - Insider Monkey
Stock Analysis | Boston Scientific OutlookTechnical Weakness and Mixed Analyst Signals - AInvest
Boston Scientific Watchman device procedure risk - Yahoo Finance
Is Boston Scientific Corporation trending in predictive chart modelsBull Run & AI Based Buy and Sell Signals - Newser
Is now a turning point for Boston Scientific Corporation2025 EndofYear Setup & Verified Momentum Stock Alerts - Newser
Boston Scientific's 196th Trading Volume Rank Amid Strategic Shifts Mixed Analyst Outlooks and Contradictory Technical Signals - AInvest
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Boston Scientific Insider Transactions Raise Concerns Over Past Year - AInvest
Possible Bearish Signals With Boston Scientific Insiders Disposing Stock - ca.finance.yahoo.com
Is Boston Scientific (BSX) Ready to Break Out Again After Reaching an All-Time High? - AInvest
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 95,234 shares of BOSTON SCIENTIFIC ($BSX) to their portfolio - Quiver Quantitative
3 Reasons Growth Investors Will Love Boston Scientific (BSX) - Yahoo Finance
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD - Yahoo Finance
Wall Street Favorite J&J Snack Foods Faces Risks, Hanesbrands' Sales Flatline, Boston Scientific Sees Continued Growth - AInvest
Exit strategy if you’re trapped in Boston Scientific CorporationFree Investment Playbook for Growing Markets - Newser
How high can Boston Scientific Corporation stock goFree Buy Alerts With Low Risk Confirmation - Newser
BOSTON SCIENTIFIC CORPORATION (BSX) - MSN
Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
Is Boston Scientific (NYSE:BSX) a Compounding Machine with Sustainable Growth and Attractive Risk-Reward Profile? - AInvest
Boston Scientific (NYSE:BSX) Is Experiencing Growth In Returns On Capital - ca.finance.yahoo.com
FDA issues alert for updated instructions for certain Boston Scientific Watchman access systems - MassDevice
Boston Scientific updates instructions of devices linked to 17 deaths - MedTech Dive
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Yahoo Finance
FDA says Watchman access alert remedied by review of IFU - BioWorld MedTech
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths - MSN
Q2 Medical Devices & SuppliesDiversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks - ca.finance.yahoo.com
Boston Scientific tells users about defibrillator problem linked to deaths, injuries - MedTech Dive
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results - Insider Monkey
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know - Yahoo Finance
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures - MassDevice
Boston Scientific stock falls after FDA discloses defibrillation lead issue - Investing.com
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Yahoo Finance
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin - The Globe and Mail
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corporation Could See a Relief Rally From SupportDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):